8.3 Transfusion Reactions, Immune Deficiencies, Anemia & BMT

Transfusion Reactions in Critically Ill Children

Transfusion saves lives in the PICU but introduces immune and volume-related emergencies. Beyond ABO-incompatible acute hemolysis (fever, flank/abdominal pain, hemoglobinuria — stop the transfusion immediately, maintain IV access with saline, and notify the blood bank), two pulmonary phenotypes dominate exam items: TRALI and TACO.

TRALI vs TACO

Transfusion-related acute lung injury (TRALI) is an immune-mediated injury producing acute hypoxemia and non-cardiogenic pulmonary edema, typically during or within six hours of transfusion. Donor antibodies against recipient leukocytes (or bioactive lipids in stored products) activate pulmonary neutrophils, causing capillary leak. The child develops dyspnea, bilateral infiltrates, fever, and often hypotension, with normal or low left-atrial pressure — it behaves like ARDS, not fluid overload. Management: stop the transfusion, ABCs, oxygen/NIV/intubation as needed, hemodynamic support, and product quarantine reporting. Diuretics do not treat the primary leak physiology.

Transfusion-associated circulatory overload (TACO) is hydrostatic pulmonary edema from too much volume too fast — especially dangerous in small children, infants with congenital heart disease, renal impairment, or chronic anemia who receive large aliquots. Expect hypertension, jugular venous distention when assessable, S3, elevated BNP, and improvement with diuresis, upright positioning, and slower future infusion rates (often with aliquot/divided dosing).

Other reactions to recognize: febrile non-hemolytic (cytokine-mediated fever), allergic/anaphylactic (urticaria to bronchospasm — epinephrine for anaphylaxis; IgA deficiency history matters), and citrate toxicity during massive/rapid transfusion causing ionized hypocalcemia (prolonged QT, tetany) treated with IV calcium.

Immune Deficiencies in the PICU

Children may enter critical care with primary immunodeficiency (e.g., severe combined immunodeficiency, chronic granulomatous disease, antibody deficiencies) or secondary immunosuppression from chemotherapy, corticosteroids, solid-organ or stem-cell transplant drugs, or malnutrition. Shared nursing implications: heightened bacterial, viral, fungal, and opportunistic infection risk; blunted inflammatory signs (fever may be the only clue); need for protective environments (positive-pressure/HEPA for selected hosts), strict hand hygiene, visitor screening, avoidance of live vaccines and fresh flowers/standing water in profound neutropenia, and early infectious-disease collaboration. Pneumocystis prophylaxis, CMV monitoring, and immunoglobulin replacement appear frequently in transplant and primary-immunodeficiency pathways — know that fever or new organ dysfunction equals infection until proven otherwise.

Anemia in Pediatric Critical Illness

Anemia in the PICU arises from blood loss, hemolysis (including SCD and microangiopathy), marrow suppression, nutritional deficiency, and iatrogenic phlebotomy. Physiologic impact depends on rate of fall, oxygen demand, and cardiopulmonary reserve — a gradual hemoglobin of 7 g/dL in a stable child differs from acute hemorrhage to the same number. Modern pediatric critical care generally favors restrictive transfusion strategies for hemodynamically stable children (often hemoglobin threshold around 7 g/dL, with higher targets in cyanotic heart disease, severe pulmonary disease, or active bleeding per team goals). Always match product attributes to the host: irradiated/CMV-safe units for transplant and many oncology patients; phenotype-matched or extended matched RBCs for alloimmunized or SCD patients; slow aliquots in infants.

Nursing actions that reduce transfusion need: minimize unnecessary labs, use low-volume sampling, control procedural bleeding, optimize nutrition and iron when appropriate, and treat the underlying driver (stop hemolysis, control hemorrhage, support marrow recovery).

Bone Marrow Transplant (Hematopoietic Cell Transplant) ICU Issues

Hematopoietic cell transplantation (HCT/BMT) cures selected malignancies and immune/metabolic diseases but creates a predictable ICU risk window. Pre-engraftment, profound pancytopenia yields bleeding, anemia, and infection. Mucositis drives pain, aspiration risk, and bacteremia from gut translocation. Key post-transplant syndromes:

1. Failure to engraft / graft rejection — persistent cytopenias beyond expected timelines; rising transfusion dependence; urgent transplant-team notification.
2. Graft-versus-host disease (GVHD) — donor T cells attack host tissues. Acute GVHD classically involves skin (rash), liver (cholestasis), and gut (secretory diarrhea, abdominal pain); grading guides immunosuppression intensification. Nursing focuses on skin integrity, massive diarrheal fluid/electrolyte replacement, infection surveillance while steroids rise, and nutritional support.
3. Sinusoidal obstruction syndrome / veno-occlusive disease (SOS/VOD) — conditioning injury to hepatic sinusoids produces painful hepatomegaly, jaundice, fluid retention/ascites, and portal hypertension; severe forms cause multiorgan failure. Weight gain, right-upper-quadrant pain, and rising bilirubin are bedside clues; fluid management is delicate — avoid overload while supporting perfusion; defibrotide may be used in established severe SOS per protocol.
4. Pulmonary complications — infection, idiopathic pneumonia syndrome, diffuse alveolar hemorrhage, and fluid overload; escalating oxygen needs warrant early ICU rescue and bronchoscopy pathways.
5. Infection timeline — early bacterial/Candida risk during neutropenia; later CMV, adenovirus, Aspergillus, and Pneumocystis depending on prophylaxis and immune reconstitution.

Family-centered care is non-optional: transplant hospitalizations are long, isolation is isolating, and parents track every fever and stool output. Clear communication about protective precautions, visitation, and when to call for respiratory change keeps the child safer. For the exam, anchor every vignette on stop-the-transfusion reflexes, TRALI versus TACO bifurcation, restrictive yet individualized anemia care, and the GVHD / SOS / infection triad after BMT.